Henry Schein — Third Quarter 2026 Earnings Summary

Henry Schein reported a 4.0% increase in total sales for the third quarter of 2026, reaching $3.5 billion, driven primarily by an 8.6% growth in U.S. dental merchandise sales. The company achieved GAAP diluted earnings per share of $1.06 and non-GAAP diluted earnings per share of $1.56, representing increases of 26.2% and 13.0% respectively compared to the prior year. Adjusted EBITDA for the quarter rose to $321 million, reflecting a 40 basis point margin expansion to 9.24%. Consequently, Henry Schein raised its full-year 2026 non-GAAP diluted EPS guidance to a range of $5.50 to $5.56 and updated its Adjusted EBITDA growth outlook to the high-single-digits.